Confusion over the FDA delay in granting full approval to Novavax’s Covid-19 vaccine deepened over the weekend, with possible ...

Here are eight possible indicators of how health secretary Robert F. Kennedy Jr. may handle U.S. vaccine policy in coming ...

Some key public health figures are taking an extraordinary step to try to shore up U.S. vaccination policy, feared to be ...

This is the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and ...

STAT senior writer Helen Branswell reflects on the trajectory of the Covid-19 pandemic: about the wishful thinking that led ...

This coming Thursday was supposed to be the deadline for federal health systems to show the patient care decision-making ...

For years, Pfizer was the only drugmaker with treatments for the disease, called ATTR-CM, but BridgeBio’s CEO said in an ...

Earlier this month, the FDA delayed a decision on whether to grant full approval to Novavax’s Covid-19 vaccine, and over the ...